Strides Pharma stock gains 18% on export of antiviral tablets for COVID-19

Strides Pharma stock gains 18% on export of antiviral tablets for COVID-19

Share price of Strides Pharma gained up to 18.22% to Rs 442.25 compared to the previous close of Rs 374.25 on BSE

Advertisement
Strides Pharma share is trading higher than its 5 day, 20 day, 50 day, 100 day and 200 day moving averagesStrides Pharma share is trading higher than its 5 day, 20 day, 50 day, 100 day and 200 day moving averages
https://akm-img-a-in.tosshub.com/businesstoday/2021-12/aseem.png
Aseem Thapliyal
  • Apr 29, 2020,
  • Updated Apr 29, 2020 1:41 PM IST

Strides Pharma share price gained in early trade today after  the firm commenced export of antiviral Strides Favipiravir tablets for treatment of coronavirus. Share price of Strides Pharma gained up to 18.22% to Rs 442.25 compared to the previous close of Rs 374.25 on BSE.

Strides Pharma share is trading higher than its 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The small  cap stock has lost 9.28% during last one year and but gained 20.44% since the beginning of this year.

Advertisement

In last one month, the stock has gained 41.56% and risen 30.38% during last one week.

Total 2.48 lakh shares amoting to turonover of Rs 10.51 crore changed hands on BSE.

Share Market LIVE: Sensex up 420 points, Nifty at 9,500; Tata Steel, Bajaj Finance, HDFC top performers

Market cap of the firm rose to Rs 3,890 crore. The firm said it has developed and commercialized Favipiravir Antiviral tablets. The product is a generic version of Avigan of Toyama Chemical, Japan.

Strides has developed Favipiravir tablets in 400mg and 200mg strengths for convenient dosage administration.

The product is currently being exported to GCC countries to treat patients under their treatment program for Covid-19. Strides will also immediately apply to Indian drug authorities to commence necessary studies and make the drug available to Indian patients expeditiously, said the pharma firm.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

Strides Pharma share price gained in early trade today after  the firm commenced export of antiviral Strides Favipiravir tablets for treatment of coronavirus. Share price of Strides Pharma gained up to 18.22% to Rs 442.25 compared to the previous close of Rs 374.25 on BSE.

Strides Pharma share is trading higher than its 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The small  cap stock has lost 9.28% during last one year and but gained 20.44% since the beginning of this year.

Advertisement

In last one month, the stock has gained 41.56% and risen 30.38% during last one week.

Total 2.48 lakh shares amoting to turonover of Rs 10.51 crore changed hands on BSE.

Share Market LIVE: Sensex up 420 points, Nifty at 9,500; Tata Steel, Bajaj Finance, HDFC top performers

Market cap of the firm rose to Rs 3,890 crore. The firm said it has developed and commercialized Favipiravir Antiviral tablets. The product is a generic version of Avigan of Toyama Chemical, Japan.

Strides has developed Favipiravir tablets in 400mg and 200mg strengths for convenient dosage administration.

The product is currently being exported to GCC countries to treat patients under their treatment program for Covid-19. Strides will also immediately apply to Indian drug authorities to commence necessary studies and make the drug available to Indian patients expeditiously, said the pharma firm.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Read more!
Advertisement